MD, H. K., MD, H. K., Ryul Kim MD, P., MD, H. J., MD, H. R. K., Joohyun Hong MD, P., . . . Seung Tae Kim MD, P. (2021). Tumor Mutational Burden as a Biomarker for Advanced Biliary Tract Cancer. SAGE Publishing.
Cita Chicago Style (17a ed.)MD, Hongsik Kim, Hana Kim MD, PhD Ryul Kim MD, Hyunji Jo MD, Hye Ryeon Kim MD, PhD Joohyun Hong MD, PhD Joon Oh Park MD, PhD Young Suk Park MD, y PhD Seung Tae Kim MD. Tumor Mutational Burden as a Biomarker for Advanced Biliary Tract Cancer. SAGE Publishing, 2021.
Cita MLA (8a ed.)MD, Hongsik Kim, et al. Tumor Mutational Burden as a Biomarker for Advanced Biliary Tract Cancer. SAGE Publishing, 2021.
Precaución: Estas citas no son 100% exactas.